Read more

March 07, 2023
1 min read
Save

Top in ID: RSV vaccines; financial incentives for antimicrobial therapy uptake

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Last week, FDA advisors recommended the approval of two respiratory syncytial virus, or RSV, vaccines for older people. It is the first time that RSV vaccines were recommended for approval.

The FDA is expected to make its decisions on the vaccines by May. It was the top story in infectious disease last week.

FDA HQ in Washington
Last week, FDA advisors recommended the approval of two RSV vaccines for older people. Image: Adobe Stock

Another top story was about a study that found incentive pay did not improve uptake of parenteral antimicrobial therapy among physicians.

Read these and more top stories in infectious disease below:

FDA advisors recommend two RSV vaccines for older adults

An FDA advisory committee recommend the approval of two respiratory syncytial virus vaccines for older people, who are among the most susceptible to severe disease, hospitalization and death from the infection. Read more.

Incentive pay did not improve uptake of OPAT among ID physicians

Financial incentive did not improve uptake of outpatient parenteral antimicrobial therapy among physicians, though uptake was already high before introduction of the incentive, suggesting that there was little room for improvement to start. Read more.

Two-drug therapy for scrub typhus more effective than monotherapy

A combination therapy of IV doxycycline and azithromycin was more effective for the treatment of severe scrub typhus than using either drug alone, according to findings published Wednesday in The New England Journal of Medicine. Read more.

Studies continue to show benefits of long-acting injections for HIV prevention

Two studies presented at the Conference on Retroviruses and Opportunistic infections demonstrated high adherence levels and acceptability of long-acting, injectable PrEP for HIV prevention among varying groups of people. Read more.

Early ID consultation for S. aureus bacteremia improves outcomes, cuts hospital stays

An infectious disease consultation within 3 1/2 days of a diagnosis of Staphylococcus aureus bacteremia was shown in a study to increase adherence to quality care indicators and decrease hospital stays compared with a later consultation. Read more.